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In Situ Characterization of Two Wireless Transmission
Schemes for Ingestible Capsules
Lei Wang, Member, IEEE, Timothy D. Drysdale, and David R. S. Cumming
Abstract—We report the experimental in situ characterization
of 30–40 MHz and 868 MHz wireless transmission schemes for
ingestible capsules, in porcine carcasses. This includes a detailed
study of the performance of a magnetically coupled near-field very
high-frequency (VHF) transmission scheme that requires only one
eighth of the volume and one quarter of the power consumption
of existing 868-MHz solutions. Our in situ measurements tested
the performance of four different capsules specially constructed
for this study (two variants of each transmission scheme), in
two scenarios. One mimicked the performance of a body-worn
receiving coil, while the other allowed the characterization of the
direction-dependent signal attenuation due to losses in the sur-
rounding tissue. We found that the magnetically coupled near-field
VHF telemetry scheme presents an attractive option for future,
miniturized ingestible capsules for medical applications.
Index Terms—Biomedical telemetry, finite-difference time-
domain (FDTD) methods, UHF radio propagation, VHF radio
propagation.
I. INTRODUCTION
THERE IS great interest in the use of wireless transmissionsystems in and around the body, for applications as diverse
as medicine [1] and personal entertainment [2]. In diagnosis and
screening of the gastrointestinal (GI) tract, self-contained wire-
less capsules with integrated sensors [3] offer significant bene-
fits such as improved patient comfort and wider test coverage,
in terms of both time and area. For example, ingestible capsules
painlessly allow unprecedented ease of access to the entire GI
tract, whereas conventional endoscopic examination leaves up
to two thirds of the small bowel unexamined and is sufficiently
uncomfortable to merit sedation [4].
The first examples of wireless medical capsules were devel-
oped beginning in the late 1950s and measured temperature [5],
pressure [6], or pH [7]. Little further progress [8] was made until
the recent development of a video capsule [4]. However, video is
only one of the several measurements that physicians wish to ob-
tain from the GI tract. Accurate measurements of temperature,
pressure, pH and other ion concentrations can reveal patholo-
gies that are undetectable by video. It is essential in many cases
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to obtain this information for the entire GI tract. Depending
on GI motility, this can take up to 72 hours. Existing capsules
with short lifetimes leave significant portions unexamined. The
battery is limited in size by patient comfort constraints, so the
power consumption must be reduced in order to improve cap-
sule longevity [9]. The key problem is the large power consumed
by the RF transmitter in overcoming the strong, frequency-de-
pendent attenuation of the signal in the human body. In experi-
mental work, Scanlon et al. [10] observed significant transmis-
sion loss of 19–25 dB at 915 MHz, using a vaginal implantable
telemeter. A capsule in the GI tract is even deeper in the body,
requiring the ability to transmit through up to 15 cm of human
tissue. While the efficiency of a small antenna increases with
frequency, so too does the attenuation of the tissue [11]. Taking
both these effects into account, finite-difference time-domain
(FDTD) simulations by Chirwa et al. [12] in the frequency range
150 MHz–1.2 GHz predicted that optimal transmission from a
pill inside a human body was achieved at 600–800 MHz.
This range does not exactly correspond with the license-free
industrial, scientific, and medical (ISM) bands that are available
to these capsules (433 MHz, 868 MHz, and 2.4 GHz in Europe
and 315 MHz, 915 MHz, and 2.4 GHz in the U.S.). Given that
prototype capsules have already been developed with telemetry
systems operating at these less-than-optimal frequency ranges
[9], [13], [14] and above [15], there is clearly a need for an
improved solution. Any such solution must be constructed from
readily available, inexpensive components in order to meet
the low-cost requirement for these one-time-only/disposable
devices.
Following the success of near-field transmission schemes in
radio-frequency identification applications [16], an attractive
approach is to use magnetic induction (coupling) [17], and
operate in the 300-kHz–30-MHz frequency band allocated to
ingestible capsule devices by the Medicines and Healthcare
products Regulatory Agency (MHRA) [18]. At these frequen-
cies, the wavelength (10 m km) is much larger
than the pill itself so it is impossible to incorporate a conven-
tional antenna arrangement. Instead, an inductor (small coil)
is employed as the radiating element. The inductor generates
an alternating magnetic field around the pill, the amplitude of
which falls with the cube of distance but will mutually couple
to a receiving coil located in the near field . To
date, there has been no published performance comparison of
the low-frequency near-field induction transmission technique
with the previously studied far-field high-frequency techniques,
for ingested capsule applications.
0018-9294/$25.00 © 2007 IEEE
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TABLE I
DETAILED SPECIFICATION OF THE FOUR CAPSULES CONSTRUCTED FOR THIS STUDY
Fig. 1. Schematic diagrams of the four ingestible capsules studied in this paper
showing the relative sizes of the radio frequency transmitter and antenna com-
ponents. The biosensor- and system-on-a-chip components are not shown.
In this paper, we report the first implementation of the
novel near-field magnetic coupling very high-frequency (VHF)
telemetry scheme, and compare its measured in situ per-
formance against similar capsules employing conventional
ultrahigh-frequency (UHF) telemetry schemes. In Section II,
we describe the construction of the capsules, their transmission
schemes (32–40 MHz and 868 MHz), and the preparation
of the porcine carcasses used for the in situ measurements.
In Section III, we outline the procedure for measuring the
in situ radiation patterns that are presented in Section IV. In
Section V, we evaluate and compare the performance of the
transmission schemes in terms of transmission loss and power
consumption, showing the improved performance afforded by
the novel near-field magnetic coupling scheme.
II. MATERIALS
Four different capsules were constructed for this study, as
shown in the schematic diagram of Fig. 1. Each capsule con-
tains sensors and circuits [19], a transmitter, and an antenna, is
powered by two SR44 cells, and is packaged in a waterproof,
nontoxic machined material (the 40-MHz capsule) or by pot-
ting in poly(dimethylsiloxane) (PDMS) (other capsules). The
key difference between the capsules is the physical size and car-
rier frequency of the telemetry system. For further details of the
capsules’ construction, including a photograph, see [20].
Two of the capsules implemented the low-frequency in-
ductive coupling method proposed in [17] at 32 and 40 MHz,
respectively; we call these the “low-frequency” capsules: LF1
(32 MHz) and LF2 (40 MHz). The other two capsules im-
plemented standard transmission schemes appropriate to the
868-MHz ISM band, but each used a different antenna; we call
these the “high-frequency” capsules: HF1 and HF2. Table I
lists the detailed specification of the four capsules.
In the high-frequency capsules, we deliberately used an-
tennas that are among the smallest and most cost-effective of
those commercially available for 868-MHz operation. Despite
this, the volume of the ferrite-cored coil inductor [21] used as
the antenna in the low-frequency capsules (LF1 and LF2) was
only 1/700th of the volume of the helical antenna in HF1 and
1/1000th of the volume of the patch antenna in HF2. Consid-
ering the transmitter sizes as well, the low-frequency telemetry
system occupied 1/8 of the volume and required 1/4 of the
power compared to the 868-MHz systems. The low-frequency
capsules LF1 and LF2 used a purpose-made FM transmitter
and the inductor coil was mounted such that its longitudinal
axis was aligned to the longitudinal axis of the capsule. The
high-frequency capsules each contained the same 868-MHz
commercial transmitter (FM-RTFQ from RFsolutions) and
used a microstrip transmission line between the transmitter and
antenna so as to minimize the RF signal loss [22]. HF1 also
had a copper ground plane of area ca. 1 sq. cm below its helical
antenna. For all four capsules, each transmitter had only a
single communication channel and used frequency-shift keying
(FSK) modulation.
A spectrum analyzer (HP4404 from Agilent) was used for RF
signal reception, in conjunction with a receiving coil antenna.
Two different home-made receive coils were constructed from
copper wire and plastic formers: a large one (25-cm diameter,
five turns) that fitted over the carcass and a small one (10-cm di-
ameter, ten turns) that was pointed at the carcass. A BNC coaxial
plug was attached to each coil, with one end of the coil attached
to the signal line and the other end to ground. The larger coil
could be easily worn by a human, omitting the plastic former
for comfort and adjusting the coil diameter for fit. Without a
former, the coil would conform to the contours of the subject’s
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body and, with a low-profile custom-built receive unit, could be
worn under clothes without being noticed by others.
Other materials required for the experiments included an in-
door motorized antenna rotator, stabilized laser line marker for
alignment, affiliated plastic rotation stands and arms, and usual
post-mortem equipment such as scalpels, stitches, and needles.
Fresh porcine carcasses were obtained from a nearby abat-
toir for use in the in situ measurements. The animals were 3–4
months old at expiration, and were slaughtered as part of rou-
tine commercial operation of the abattoir; they were not slaugh-
tered specifically for our experiment. None of the carcasses had
been bled out after slaughter. This was an advantage because we
wanted the experimental conditions to mimic as closely as pos-
sible the conditions encountered in living tissue, where the pres-
ence of blood and other body fluids is expected to increase the
overall conductivity and, therefore, reduce the transmissivity.
The carcasses weighed approximately 25–35 kg.
III. METHOD
This section describes the measurement procedures for
determining the direction-dependent transmission loss of the
pills. The experiments were conducted in a large concrete
post-mortem room of approximate dimension 7 m by 8 m with
a 6-m high ceiling.
For the in situ measurements, the capsules were surgically
embedded in porcine carcasses. Each capsule was measured in
three different orientations: one vertical (with the in situ capsule
parallel to the cranial–caudal line) and two horizontal (with the
in situ capsule parallel to either the dorsal–ventral or lateral–me-
dial line). The embedding procedure was as follows. With the
carcass lying on an operation table, a midline incision was made
along the abdomen from the xiphoid process of the sternum to
the proximal inguinal teat, providing good access to the GI tract.
For the dorsal–ventral (first horizontal) orientation, the capsule
was inserted into a cut made to the diaphragm about 5 cm from
the ventral attachment point. For the medial—lateral (second
horizontal) orientation, the capsule was anchored by tying it to
the intestinal mesentery. For the cranial–caudal (vertical) orien-
tation, the capsule was inserted into the coils of the small in-
testine. In all three cases, the capsule was located within the ab-
domen between the T14 (thoracic) and L2 (lumbar) levels. After
embedding the capsule, the incisions were sutured with nylon.
During the measurements, the carcass was hung by its
forelegs from a metal hook and metal wire, with the head tied
up with ordinary string to promote a vertical orientation of the
spine. The low end of the carcass was approximately 1 m above
the room ground. Two separate setups were used to obtain the
measurements, as illustrated in the diagrams of Fig. 2, with the
set-up for measuring the transverse directions in Fig. 2(a) and
the azimuthal directions in Fig. 2(b). The transverse measure-
ment mimics a body-worn receive coil, while the azimuthal
measurements allow the direction-dependent transmission
losses to be determined.
Transverse measurements were conducted on one horizontal
(dorsal–ventral or lateral–medial) orientation only, due to time
constraints, while azimuthal measurements were conducted for
Fig. 2. Diagram of experimental set-up for in situ measurements. (a) Trans-
verse measurement (large coil). (b) Azimuthal measurement (small coil). The
size of the capsule is exaggerated for clarity.
all three orientations. After each measurement was conducted,
the orientation of the pill was rechecked by carefully reopening
the incisions. The large antenna was placed completely around
the carcass, with its longitudinal axis co-aligned with that of the
carcass. The zero position was defined as the coil being centered
upon the capsule location. Measurements were taken at 10-cm
intervals while the coil was lowered, until the final measurement
which was taken with the coil below the carcass, as illustrated
in Fig. 2(a).
The azimuthal measurements were taken with the small re-
ceive antenna, mounted upon the motorized antenna rotator via
plastic support arms that were adjusted to obtain a small separa-
tion between the carcass and the front face of the antenna. This
antenna scribed an arc of radius cm around the capsule,
yielding a separation from the carcass that varied from 1–3 cm
because the cross section of the carcass was not round. Mea-
surements were taken at angular steps of 30 , with 0 defined
as being at the ventral incision point and the direction of posi-
tive rotation being ventral to lateral. The antenna was mounted
so that it was oriented with its longitudinal axis normal to the
surface of the carcass for all steps. Both clockwise and anti-
clockwise rotations were performed to eliminate hysteresis. In
addition to the in situ measurements, the radiation pattern of
the 32-MHz capsule LF1 was characterized by taking azimuthal
measurements at heights of 40 cm to 40 cm in 10-cm steps. We
do not present the radiation patterns of the helical and patch an-
tennas here because they are well known in the literature [23].
For all measurements, the output of the receive coil was con-
nected via coaxial cable to the spectrum analyzer, located 3 m
away. All other objects were cleared from a 3-m radius around
the experiment. The transmission loss (in dB) for any direc-
tion was calculated by subtracting the power (in dBm) received
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when the capsule was embedded in the carcass (in situ measure-
ment) from the power received in an identical setup but without
the carcass present (control measurement). In order to correctly
locate the capsule during the control measurements, a plastic
stand was used. For each in situ and control measurement, the
spectrum analyzer’s frequency range was centred upon the cap-
sule signal with a 100-kHz span and the RF noise floor readings
were recorded. Each measurement was averaged 20 times.
Each capsule was powered by two 3-V SR44 battery cells.
Battery lifetime tests conducted on each capsule indicated that
the cells provide approximately 50 h effective lifetime for the
low-frequency capsules and 12.5 h for the high-frequency cap-
sules. For the sake of accurate characterization of in situ signal
attenuation, the total measurement time span for all capsules
was limited to much less than 12.5 h and the supply voltage was
recorded before and after every measurement.
A full-vector numerical electromagnetic solver tool based on
the FDTD method [24] was used to model the “in air” (control)
and in situ radiation patterns of the antenna used in the low-fre-
quency capsules LF1 and LF2. Small loop antennas have a radi-
ation pattern that is independent of the exact geometry and can
be accurately modelled with a single magnetic dipole [23]. The
simulation domain for both simulations was a cube of 7.5 m in
length per side, comprised of 320 by 320 by 320 cubic mesh
cells. The domain was bounded by the perfectly matched layer
condition, of 10 cells thickness on all sides. A single frequency
source of 32 MHz with a raised cosine envelope excited a single
magnetic field component at the centre of the domain. The sim-
ulations were run until convergence using a time step of 45 ps.
The porcine carcass was represented by a cylinder of diameter
10 cells (23 cm) and height 36 cells (84 cm), having a com-
plex refractive index of . The refractive index was
arbitrarily chosen to equal to the average of the individual re-
fractive index values for various body tissue types at 32 MHz as
presented in [25] because a detailed evaluation of the effective
complex refractive index of the carcass was outside the scope of
this paper. We note that there is no need to model the detailed
structure of the carcass because its dimensions are small with
respect to the wavelength.
IV. RESULTS
The radiation patterns of the 32-MHz capsule LF1 in air are
shown in Fig. 3, with the pill oriented vertically in Fig. 3(a)
and horizontally in Fig. 3(b). The field patterns are cut away
for clarity and a cylinder (not to scale) indicates the capsule
orientation for clarity. These patterns correspond to those that
are predicted by the equations in [17], when convolved with
the receiving coil’s radiation pattern. As expected for the ver-
tically oriented capsule, there is a small trough (10 dB) at zero
vertical displacement. Thus, it was decided to conduct the az-
imuthal in situ measurements for the vertically oriented low-fre-
quency capsules at a vertical displacement of approximately 15
cm in order to obtain the strongest signal and hence highest
quality characterization of any attenuation in the transmission
path. The radiation pattern for the horizontal case in Fig. 3(b)
differs from that in Fig. 3(a) because the relative orientations of
Fig. 3. Cylindrical coordinate plots of the measured radiation patterns of the
LF1 low-frequency capsule (32 MHz) in air (control measurement), for (a) pill
oriented vertically, and (b) pill oriented horizontally (axis lying along 0  
180 ). The orientation of the pill is indicated by a cylinder (not to scale). The
field patterns are partly cut away for clarity.
the transmit and receive antennas are different. Measurements
of the horizontally oriented LF pills are, therefore, expected to
obtain the greatest signal strength at a zero vertical displace-
ment, as is known to be the case for the HF capsules.
The results obtained from the transverse measurement setup,
designed to mimic a body-worn coil, are presented in Fig. 4.
Both the low-frequency capsules (LF1 and LF2) gave their
highest received powers ( 84 and 89 dBm, respectively)
when the receive coil was at or near the same height as the cap-
sule. The received signal power reduced as the coil was moved
further away from the capsules’ position in the abdomen. This
suggests that while acceptable received signal powers will
be available for the coil located anywhere on the body, the
optimum placement would be as close as possible to where
the capsule will be when it is traversing the region of interest.
The situation is similar for the high-frequency capsules HF1
and HF2, although the maximum received powers for these
capsules were higher at 72 and 66 dBm, respectively. The
slight offset in the position of the maximum received power is
always less than 8 cm, and we attribute this to error in aligning
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Fig. 4. Graph of the measured signal power as a function of the vertical dis-
placement of the large receiving coil (transverse measurement, see Fig. 3(a) for
each of the four capsules. In each case, the capsule is oriented horizontally.
Fig. 5. Polar plots of control data for (a) the vertical and (b) the horizontal
orientation of the capsules. Only one data set from each transmission scheme is
shown: LF1 32 MHz with the solid line and HF1 868 MHz (JJB antenna) with
the dotted line.
the receive coil to the expected position of the capsule ( 3 cm)
and the internal organs slumping when the carcass is hung,
lowering the position of the capsule ( 5 cm). While the signal
received from the HF capsules is approximately 17 dB stronger
Fig. 6. Polar plots of the transmission of the embedded capsules (i.e., in situ
measurement normalized against the control measurement) for (a) the vertical
and (b) the horizontal orientation of the capsules. Only one data set from
each transmission scheme is shown: LF1 32 MHz with the solid line and HF1
868 MHz (JJB antenna) with the dotted line.
on average, this does not necessarily mean that the HF capsules
represent a better solution as we will show later when we
consider signal-to-noise ratios and relative power consumption.
The azimuthal measurements are intended to provide a direc-
tion-dependent characterization of the transmission loss in the
carcass, defined as the difference between the received signal
power when the capsule is in air and in situ. We present the con-
trol data first. Fig. 5 shows the received signal power recorded
in the azimuthal control experiments, with the capsules ori-
ented vertically in Fig. 5(a) and horizontally in Fig. 5(b). In the
vertical orientation, the radiation is isotropic for both capsules
with an average of 50 dBm received from capsule HF1 while
an average of 97 dBm was received from capsule LF1. In
the horizontal orientation, the radiation pattern from capsule
HF1 remained isotropic, with similar averaged received power
( 50 dBm). The radiation pattern of the low-frequency capsule
LF1 exhibits the expected double lobe shape that was revealed
in Fig. 3(b). On average, the received signal was 96 dBm,
with the peaks of the lobes approximately 17 dB stronger than
the troughs between them. In these control experiments con-
ducted in air, the received signal powers for the high-frequency
capsules were 65 dBm and 72 dBm, which were some
13–20 dB larger than that for the low-frequency capsules.
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TABLE II
SUMMARY OF MEASUREMENT RESULTS
Fig. 6 shows the direction dependent transmission loss (i.e.,
in situ data normalized to the control data of Fig. 5), with the
capsules oriented vertically in Fig. 6(a) and horizontally in
Fig. 6(b). In the vertical orientation, the 868-MHz capsule HF1
experiences strong attenuation of 26 dB on average, and there
is significant channel fading of 52 dB in the dorsal direction
that we attribute to stronger tissue absorption in that part of
the carcass. Conversely, the 32-MHz capsule LF1 fares much
better, experiencing attenuation of only 5 dB on average with
no direction-dependent channel fading. In the horizontal ori-
entation, both capsules perform better. The 868-MHz capsule
exhibited 15 dB of attenuation on average and 17 dB of channel
fading in the dorsal direction, while the 32-MHz capsule had
very low attenuation of only 1 dB on average and a nearly
omnidirectional antenna pattern. These measurement results
are summarized in Table II.
We performed simulations that mimicked both the control and
in situ azimuthal experiments for the case of the low-frequency
capsule LF1. The simulation results were in good agreement
with the measured results but we present only a selection for
compactness. The simulated radiation pattern from a horizon-
tally oriented 32-MHz capsule in air is shown in Fig. 7(a), corre-
sponding to the measured control result in Fig. 5(b) that is drawn
with the solid line. The simulated in situ transmission of a hor-
izontally oriented 32-MHz capsule in shown in Fig. 7(b), and
is normalized against the simulated control data from Fig. 7(a).
The simulation data shown in Fig. 7(b) corresponds to the in situ
measurement data plotted with the solid line in Fig. 6(b). Quali-
tatively, the simulated results in Fig. 7 agree well with the mea-
sured data in Figs. 5 and 6. We note that the magnitude of the
simulated in situ radiation pattern is slightly enhanced overall
by 1.2 dB compared to the simulated control radiation pattern
because the carcass dielectric increases the effective electrical
size and hence efficiency of the radiating element.
V. DISCUSSION
As expected, the magnetic near fields employed by the low-
frequency transmission scheme are relatively unimpeded by the
tissues, fluids, etc. in the carcass whereas the high-frequency
far fields are strongly absorbed. For the 868-MHz scheme, the
strong channel fading in the dorsal direction, as well as the gen-
erally lower level of signal received on the posterior side, is a
consequence of the arrangement of organs, bone, fat, and blood
within the carcass, each having different dielectric properties
Fig. 7. Polar plots of simulated data at 32 MHz for the horizontally oriented
capsule LF1: (a) control or radiation pattern, and (b) transmission of embedded
capsule (i.e., in situ simulation normalized against control).
and absorption coefficients [12]. Thus, the low-frequency cap-
sules have the advantage of avoiding data loss from channel
fading. This is important because a capsule deployed in a live
subject would be almost constantly in motion throughout the GI
tract and also its orientation would be uncontrollable.
Furthermore, we estimate that the low-frequency capsules
have the advantage of a better signal-to-noise ratio for a given
level of power consumption, and, therefore, a higher quality
signal. The measured power consumption figures indicate that
the high-frequency capsules are transmitting at up to four times
the power, or 6 dB stronger.
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Subtracting the experimental noise floor (see Table II) from
the HF capsules’ average received signal powers in the in situ
measurements gives a carrier signal-to-noise ratios (CSNRs) in
the range of 11–16 dB depending on vertical/horizontal cap-
sule orientation, whereas the LF capsules have a superior CSNR
of 19 dB. This calculation is dependent upon the background
noise where we conducted our measurements ( 115 dBm for
HF and 95 dBm for LF), but it also helps illustrate the ad-
vantage of using a near-field transmission scheme in an unli-
censed band—nearby users contribute less to the background
noise due to the reduction in near-field strength compared
to the reduction associated with the propagating fields em-
ployed at 868 MHz.
Unfortunately for the 868-MHz transmitter, the data sheet in-
dicates that its power consumption cannot be lowered below
20 mW, so the low-frequency transmission scheme that con-
sumes only 5 mW (see Table I) is more attractive for long-life-
time capsules. The low-frequency scheme is inherently more
power efficient because it takes advantage of the high amplitude
of the near fields ( cm at 32 MHz) compared
to that of the propagating far fields ( cm at
868 MHz).
VI. CONCLUSION
We constructed four ingestible capsules with the aim of com-
paring the performance of a novel near-field magnetically cou-
pled transmission scheme for the 30-MHz ingestible capsule
band against an existing commercial transmission scheme for
the 868-MHz ISM band. We experimentally characterized the
radiation pattern of the low-frequency antenna (a coil, operating
at 32 MHz) in good agreement to theory, then conducted in situ
measurements in a porcine carcass. Two experiments were con-
ducted. The first mimicked the use of a body-worn receiving coil
and showed that, like the high-frequency scheme, the best posi-
tion for the receiving coil is near the location of the capsule.
The second characterized the direction-dependent loss of the
32-MHz and 868-MHz transmission paths through the porcine
carcass. Normalized to control measurements recorded in air,
data from the second experiment emphasized the advantage of
the near-field magnetically coupled 32-MHz scheme in two key
areas. First, the tissue attenuation was only 1–5 dB on average at
32 MHz with no channel fading, but was 15–26 dB on average at
868 MHz with channel fading of up to 52 dB (corresponding to
likely loss of data). We estimate the low-frequency capsule has
better CSNR for similar levels of power consumption, in addi-
tion to having over 50 h of battery lifetime (four times the battery
life of the 868-MHz scheme). Finally, we note that the perfor-
mance advantages of the low-frequency scheme are coupled to
a much smaller form factor, at one eighth of the volume of the
868-MHz scheme, allowing much greater miniaturization of fu-
ture ingestible capsules, and, hence, increased patient comfort.
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